Search research articles
Contact Us
Filters
Showing results (501-510 of 527) with videos related to
Page
of 53
Sort By:
Scientific Reports
|
December 7, 2021
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
Chung-Feng Huang, Hsing-Tao Kuo, Te-Sheng Chang, et al.
Journal of Viral Hepatitis
|
September 13, 2025
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs
Angela Chau, Jie Li, Dae Won Jun, et al.
Hepatology International
|
January 21, 2024
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
Ming-Lung Yu, Chi-Ming Tai, Lein-Ray Mo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 6, 2022
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan
Ching-Chu Lo, Chung-Feng Huang, Pin-Nan Cheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine
Jiyoon Park, An K Le, Tai-Chung Tseng, et al.
JHEP Reports : Innovation in Hepatology
|
July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Zobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 3, 2021
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
Chi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, et al.
Metabolism: Clinical and Experimental
|
September 13, 2024
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
Xu-Fen Zeng, Krista A Varady, Xiang-Dong Wang, et al.
Clinical and Molecular Hepatology
|
January 9, 2024
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, et al.
Hepatology International
|
February 27, 2025
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, et al.
Page
of 53
Search research articles
Search
Showing results (501-510 of 527) with videos related to
Sort By:
Page
of 53
Scientific Reports
|
December 7, 2021
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
Chung-Feng Huang, Hsing-Tao Kuo, Te-Sheng Chang, et al.
Journal of Viral Hepatitis
|
September 13, 2025
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs
Angela Chau, Jie Li, Dae Won Jun, et al.
Hepatology International
|
January 21, 2024
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
Ming-Lung Yu, Chi-Ming Tai, Lein-Ray Mo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 6, 2022
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan
Ching-Chu Lo, Chung-Feng Huang, Pin-Nan Cheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine
Jiyoon Park, An K Le, Tai-Chung Tseng, et al.
JHEP Reports : Innovation in Hepatology
|
July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Zobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 3, 2021
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
Chi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, et al.
Metabolism: Clinical and Experimental
|
September 13, 2024
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
Xu-Fen Zeng, Krista A Varady, Xiang-Dong Wang, et al.
Clinical and Molecular Hepatology
|
January 9, 2024
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, et al.
Hepatology International
|
February 27, 2025
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, et al.
Page
of 53